{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T04:10:05Z","timestamp":1745640605052,"version":"3.40.4"},"reference-count":141,"publisher":"Georg Thieme Verlag KG","issue":"01","funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"crossref","award":["KL2TR002379"],"award-info":[{"award-number":["KL2TR002379"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["DK117861"],"award-info":[{"award-number":["DK117861"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>The field of ribonucleic acid (RNA) biology has revealed an array of noncoding RNA species, particularly long noncoding RNAs (lncRNAs), which play crucial roles in liver disease pathogenesis. This review explores the diverse functions of lncRNAs in liver pathology, including metabolic-associated steatotic liver disease, hepatocellular carcinoma, alcohol-related liver disease, and cholangiopathies such as primary sclerosing cholangitis and cholangiocarcinoma. We highlight key lncRNAs that regulate lipid metabolism, inflammation, fibrosis, and oncogenesis in the liver, demonstrating their diagnostic and therapeutic potential. Emerging RNA-based therapies, such as mRNA therapy, RNA interference, and antisense oligonucleotides, offer approaches to modulate lncRNA activity and address liver disease at a molecular level. Advances in sequencing technologies and bioinformatics pipelines are simultaneously enabling the identification and functional characterization of novel lncRNAs, driving innovation in personalized medicine. In conclusion, this review highlights the potential of lncRNAs as biomarkers and therapeutic targets in liver disease and emphasizes the need for further research into their regulatory mechanisms and clinical applications.<\/jats:p>","DOI":"10.1055\/a-2490-1921","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:12:56Z","timestamp":1732752776000},"page":"001-014","source":"Crossref","is-referenced-by-count":1,"title":["LncRNAs, RNA Therapeutics, and Emerging Technologies in Liver Pathobiology"],"prefix":"10.1055","volume":"45","author":[{"given":"Abid A.","family":"Anwar","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota"},{"name":"Gastroenterology Research Unit, Mayo Clinic and Foundation, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Jalan-Sakrikar","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota"},{"name":"Gastroenterology Research Unit, Mayo Clinic and Foundation, Rochester, Minnesota"},{"name":"Mayo Clinic Center for Cell Signaling in Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Huebert","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota"},{"name":"Gastroenterology Research Unit, Mayo Clinic and Foundation, Rochester, Minnesota"},{"name":"Mayo Clinic Center for Cell Signaling in Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.molcel.2023.01.010","article-title":"Reversing the central dogma: RNA-guided control of DNA in epigenetics and genome editing","volume":"83","author":"H Y Chang","year":"2023","journal-title":"Mol Cell"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.gpb.2014.04.002","article-title":"Ribogenomics: the science and knowledge of RNA","volume":"12","author":"J Wu","year":"2014","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1201\/9781003109242","volume-title":"RNA, the Epicenter of Genetic Information: A New Understanding of Molecular Biology","author":"J Mattick","year":"2022","edition":"1 st ed."},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"L Statello","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1042\/EBC20200069","article-title":"Comparative genomics in the search for conserved long noncoding RNAs","volume":"65","author":"M W Szcze\u015bniak","year":"2021","journal-title":"Essays Biochem"},{"issue":"09","key":"ref6","doi-asserted-by":"crossref","first-page":"eaao2110","DOI":"10.1126\/sciadv.aao2110","article-title":"How do lncRNAs regulate transcription?","volume":"3","author":"Y Long","year":"2017","journal-title":"Sci Adv"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"e136336","DOI":"10.1172\/JCI136336","article-title":"Identification of human long noncoding RNAs associated with nonalcoholic fatty liver disease and metabolic homeostasis","volume":"131","author":"X Ruan","year":"2021","journal-title":"J Clin Invest"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s12013-024-01278-w","article-title":"LncRNA MEG3 restrains hepatic lipogenesis via the FOXO1 signaling pathway in HepG2 cells","volume":"82","author":"X Meng","year":"2024","journal-title":"Cell Biochem Biophys"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"111444","DOI":"10.1016\/j.intimp.2023.111444","article-title":"LncRNA Gm28382 promotes lipogenesis by interacting with miR-326-3p to regulate ChREBP signaling pathway in NAFLD","volume":"127","author":"S Yang","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.7555\/JBR.37.20230075","article-title":"Long noncoding RNA lnc_217 regulates hepatic lipid metabolism by modulating lipogenesis and fatty acid oxidation","volume":"37","author":"X Yuan","year":"2023","journal-title":"J Biomed Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"147747","DOI":"10.1016\/j.gene.2023.147747","article-title":"LncRNA AK142643 promotes hepatic lipid accumulation by upregulating CD36 via interacting with IGF2BP2","volume":"887","author":"P Wang","year":"2023","journal-title":"Gene"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10616-023-00614-x","article-title":"LncRNA HOTAIR accelerates free fatty acid-induced inflammatory response in HepG2 cells by recruiting SRSF1 to stabilize MLXIPL mRNA","volume":"76","author":"B Guo","year":"2024","journal-title":"Cytotechnology"},{"issue":"27","key":"ref13","first-page":"42431","article-title":"LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p\/ZEB1 signaling pathway","volume":"7","author":"S P Li","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1002\/jcp.28450","article-title":"Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease","volume":"234","author":"X Shen","year":"2019","journal-title":"J Cell Physiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"734643","DOI":"10.3389\/fmed.2021.734643","article-title":"Long non-coding RNA MALAT1: a key player in liver diseases","volume":"8","author":"J Lu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"101863","DOI":"10.1016\/j.redox.2021.101863","article-title":"Long non-coding RNA Meg3 deficiency impairs glucose homeostasis and insulin signaling by inducing cellular senescence of hepatic endothelium in obesity","volume":"40","author":"X Cheng","year":"2021","journal-title":"Redox Biol"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/genes11050545","article-title":"Expression of the long noncoding RNA GAS5 correlates with liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"11","author":"M H Han","year":"2020","journal-title":"Genes (Basel)"},{"issue":"07","key":"ref18","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41418-023-01183-4","article-title":"GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p\/MARCH7\/NLRP3 axis-mediated pyroptosis","volume":"30","author":"T Chen","year":"2023","journal-title":"Cell Death Differ"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1080\/21655979.2022.2026858","article-title":"Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p\/NOTCH2 axis","volume":"13","author":"J Cui","year":"2022","journal-title":"Bioengineered"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000822","article-title":"Conserved long noncoding RNA TILAM promotes liver fibrosis through interaction with PML in HSCs","author":"C Sun","year":"2024","journal-title":"Hepatology"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1002\/cam4.5263","article-title":"Long noncoding RNA HULC regulates the NF-\u03baB pathway and represents a promising prognostic biomarker in liver cancer","volume":"12","author":"S Liu","year":"2023","journal-title":"Cancer Med"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3390\/ijms25021258","article-title":"Combinatorial gene expression profiling of serum HULC, HOTAIR, and UCA1 lncRNAs to differentiate hepatocellular carcinoma from liver diseases: a systematic review and meta-analysis","volume":"25","author":"L Lumkul","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"02","key":"ref23","first-page":"1549","article-title":"Long non-coding RNA detection based on multi-probe-induced rolling circle amplification for hepatocellular carcinoma early diagnosis","volume":"95","author":"Y Yao","year":"2023","journal-title":"Anal Chem"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"19502","DOI":"10.1038\/s41598-022-23802-9","article-title":"Knockdown of the long noncoding RNA PURPL induces apoptosis and sensitizes liver cancer cells to doxorubicin","volume":"12","author":"T Berhane","year":"2022","journal-title":"Sci Rep"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41598-022-26643-8","article-title":"ST8SIA6-AS1 contributes to hepatocellular carcinoma progression by targeting miR-142-3p\/HMGA1 axis","volume":"13","author":"T Feng","year":"2023","journal-title":"Sci Rep"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1186\/s12885-023-11107-7","article-title":"GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K\/AKT pathway","volume":"23","author":"R Chen","year":"2023","journal-title":"BMC Cancer"},{"issue":"08","key":"ref27","doi-asserted-by":"crossref","first-page":"e0289552","DOI":"10.1371\/journal.pone.0289552","article-title":"Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma","volume":"18","author":"Y L Peng","year":"2023","journal-title":"PLoS One"},{"issue":"08","key":"ref28","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3748\/wjg.v30.i8.919","article-title":"Lipid metabolism-related long noncoding RNA RP11-817I4.1 promotes fatty acid synthesis and tumor progression in hepatocellular carcinoma","volume":"30","author":"R Y Wang","year":"2024","journal-title":"World J Gastroenterol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"216620","DOI":"10.1016\/j.canlet.2024.216620","article-title":"LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity","volume":"584","author":"M Fei","year":"2024","journal-title":"Cancer Lett"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.trsl.2017.09.001","article-title":"Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells","volume":"190","author":"F Leti","year":"2017","journal-title":"Transl Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.biopha.2018.03.105","article-title":"Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma","volume":"102","author":"E A Toraih","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/iub.2137","article-title":"Silencing of lncRNA SNHG20 delays the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma via regulating liver Kupffer cells polarization","volume":"71","author":"B Wang","year":"2019","journal-title":"IUBMB Life"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41420-022-01234-8","article-title":"LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2","volume":"8","author":"H Wang","year":"2022","journal-title":"Cell Death Discov"},{"issue":"06","key":"ref34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hep4.1061","article-title":"LncRNA AK054921 and AK128652 are potential serum biomarkers and predictors of patient survival with alcoholic cirrhosis","volume":"1","author":"Z Yang","year":"2017","journal-title":"Hepatol Commun"},{"issue":"19","key":"ref35","doi-asserted-by":"crossref","first-page":"23233","DOI":"10.18632\/aging.203614","article-title":"Long non-coding RNA CRNDE as potential biomarkers facilitate inflammation and apoptosis in alcoholic liver disease","volume":"13","author":"Y Yan","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"02","key":"ref36","first-page":"28","article-title":"Identification and functional characterization of alternative transcripts of LncRNA HNF1A-AS1 and their impacts on cell growth, differentiation, liver diseases, and in response to drug induction","volume":"10","author":"J Jin","year":"2024","journal-title":"Noncoding RNA"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"104559","DOI":"10.1016\/j.yexmp.2020.104559","article-title":"Altered regulation of LncRNA analysis of human alcoholic hepatitis with Mallory-Denk Bodies (MDBs) is revealed by RNA sequencing","volume":"117","author":"B Zhong","year":"2020","journal-title":"Exp Mol Pathol"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"9147","DOI":"10.18632\/aging.205861","article-title":"Identifying competing endogenous RNA regulatory networks and hub genes in alcoholic liver disease for early diagnosis and potential therapeutic target insights","volume":"16","author":"S Y Sun","year":"2024","journal-title":"Aging (Albany NY)"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/hep.31284","article-title":"Hepatitis B virus DNA polymerase restrains viral replication through the CREB1\/HOXA distal transcript antisense RNA homeobox A13 axis","volume":"73","author":"X Zhao","year":"2021","journal-title":"Hepatology"},{"issue":"02","key":"ref40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/CBM-203169","article-title":"Epigenetically-regulated serum GAS5 as a potential biomarker for patients with chronic hepatitis B virus infection","volume":"32","author":"Y Guo","year":"2021","journal-title":"Cancer Biomark"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.2147\/JIR.S423321","article-title":"Serum exosomal long noncoding RNA growth arrest-specific 5 predicts 3-month mortality in acute-on-chronic hepatitis B liver failure","volume":"16","author":"C X Sun","year":"2023","journal-title":"J Inflamm Res"},{"issue":"24","key":"ref42","doi-asserted-by":"crossref","first-page":"e2306810","DOI":"10.1002\/advs.202306810","article-title":"HOXA-AS2 epigenetically inhibits HBV transcription by recruiting the MTA1-HDAC1\/2 deacetylase complex to cccDNA minichromosome","volume":"11","author":"Y Qin","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"100269","DOI":"10.1016\/j.aohep.2020.09.013","article-title":"Long noncoding RNA LINC01189 is associated with HCV-hepatocellular carcinoma and regulates cancer cell proliferation and chemoresistance through hsa-miR-155-5p","volume":"22","author":"Y Yao","year":"2021","journal-title":"Ann Hepatol"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.31656","article-title":"Inhibition of long noncoding RNA Linc-Pint by hepatitis C virus in infected hepatocytes enhances lipogenesis","volume":"74","author":"M Khatun","year":"2021","journal-title":"Hepatology"},{"issue":"03","key":"ref45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/infdis\/jiaa325","article-title":"Upregulation of the long noncoding RNA HULC by hepatitis C virus and its regulation of viral replication","volume":"226","author":"J Kitabayashi","year":"2022","journal-title":"J Infect Dis"},{"issue":"05","key":"ref46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"J M Banales","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"25","key":"ref47","first-page":"2501","article-title":"Primary sclerosing cholangitis","volume":"375","author":"K N Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"issue":"02","key":"ref48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.joim.2024.03.006","article-title":"Danhongqing formula alleviates cholestatic liver fibrosis by downregulating long non-coding RNA H19 derived from cholangiocytes and inhibiting hepatic stellate cell activation","volume":"22","author":"M Li","year":"2024","journal-title":"J Integr Med"},{"issue":"06","key":"ref49","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","article-title":"Mdr2 (Abcb4)-\/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes","volume":"43","author":"Y Popov","year":"2005","journal-title":"J Hepatol"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.29838","article-title":"Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans","volume":"68","author":"X Li","year":"2018","journal-title":"Hepatology"},{"issue":"03","key":"ref51","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/hep.29145","article-title":"The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice","volume":"66","author":"X Li","year":"2017","journal-title":"Hepatology"},{"issue":"01","key":"ref52","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/cells9010190","article-title":"Cholangiocyte-derived exosomal lncRNA H19 promotes macrophage activation and hepatic inflammation under cholestatic conditions","volume":"9","author":"X Li","year":"2020","journal-title":"Cells"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/s41401-023-01145-z","article-title":"LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles","volume":"44","author":"X J Li","year":"2023","journal-title":"Acta Pharmacol Sin"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.30662","article-title":"Cholangiocyte-derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis","volume":"70","author":"R Liu","year":"2019","journal-title":"Hepatology"},{"issue":"04","key":"ref55","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jhep.2021.12.014","article-title":"Long non-coding RNA ACTA2-AS1 promotes ductular reaction by interacting with the p300\/ELK1 complex","volume":"76","author":"A Navarro-Corcuera","year":"2022","journal-title":"J Hepatol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"816433","DOI":"10.3389\/fimmu.2022.816433","article-title":"Effect of LncRNA XIST on immune cells of primary biliary cholangitis","volume":"13","author":"C She","year":"2022","journal-title":"Front Immunol"},{"issue":"08","key":"ref57","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1055\/a-1386-3912","article-title":"Management of intrahepatic cholestasis of pregnancy: recommendations of the Working Group on Obstetrics and Prenatal Medicine - Section on Maternal Disorders","volume":"81","author":"C Hagenbeck","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"10","key":"ref58","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41419-018-1013-z","article-title":"Linc02527 promoted autophagy in Intrahepatic cholestasis of pregnancy","volume":"9","author":"J Hu","year":"2018","journal-title":"Cell Death Dis"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"8858326","DOI":"10.1155\/2021\/8858326","article-title":"Diagnostic and prognostic value of long noncoding RNAs as potential novel biomarkers in intrahepatic cholestasis of pregnancy","volume":"2021","author":"S Zou","year":"2021","journal-title":"BioMed Res Int"},{"issue":"01","key":"ref60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-024-00533-x","article-title":"Biliary atresia","volume":"10","author":"P KH Tam","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"02","key":"ref61","first-page":"739","article-title":"Role of the long non\u2013coding RNA\u2013Annexin A2 pseudogene 3\/Annexin A2 signaling pathway in biliary atresia\u2013associated hepatic injury","volume":"43","author":"Y Nuerzhati","year":"2019","journal-title":"Int J Mol Med"},{"issue":"03","key":"ref62","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1080\/21655979.2022.2041321","article-title":"Role of long non-coding RNA-adducin 3 antisense RNA1 in liver fibrosis of biliary atresia","volume":"13","author":"Y Ye","year":"2022","journal-title":"Bioengineered"},{"issue":"04","key":"ref63","doi-asserted-by":"crossref","first-page":"903","DOI":"10.31557\/APJCP.2020.21.4.903","article-title":"Survival of patients with cholangiocarcinoma receiving surgical treatment in an O. viverrini endemic area in Thailand: a retrospective cohort study","volume":"21","author":"S Chansitthichok","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"issue":"03","key":"ref64","doi-asserted-by":"crossref","first-page":"e2029","DOI":"10.1002\/cnr2.2029","article-title":"Role of long non-coding RNAs in cholangiocarcinoma: a systematic review and meta-analysis","volume":"7","author":"P Shobeiri","year":"2024","journal-title":"Cancer Rep (Hoboken)"},{"issue":"48","key":"ref65","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.3748\/wjg.v13.i48.6478","article-title":"JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?","volume":"13","author":"O V Smirnova","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"04","key":"ref66","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41417-024-00726-2","article-title":"LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2\/STAT3 signaling","volume":"31","author":"S Yu","year":"2024","journal-title":"Cancer Gene Ther"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/s44319-024-00075-z","article-title":"TGF\u03b2-induced long non-coding RNA LINC00313 activates Wnt signaling and promotes cholangiocarcinoma","volume":"25","author":"P Papoutsoglou","year":"2024","journal-title":"EMBO Rep"},{"issue":"04","key":"ref68","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41417-022-00500-2","article-title":"Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p\/SOX9 axis through PI3K\/AKT pathway","volume":"30","author":"Q Ni","year":"2023","journal-title":"Cancer Gene Ther"},{"issue":"11","key":"ref69","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41419-022-05412-5","article-title":"JUND\/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202\/GPX4 axis","volume":"13","author":"S Lei","year":"2022","journal-title":"Cell Death Dis"},{"issue":"01","key":"ref70","doi-asserted-by":"crossref","first-page":"509","DOI":"10.18632\/aging.203828","article-title":"PSMA3-AS1 induced by transcription factor PAX5 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-376a-3p to up-regulate LAMC1","volume":"14","author":"D Sun","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"10","key":"ref71","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41419-020-03029-0","article-title":"LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1\/Hippo axis","volume":"11","author":"F Li","year":"2020","journal-title":"Cell Death Dis"},{"issue":"08","key":"ref72","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41419-020-02896-x","article-title":"LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a\/neuropilin-1 axis","volume":"11","author":"H Zhu","year":"2020","journal-title":"Cell Death Dis"},{"issue":"03","key":"ref73","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.3192","article-title":"The landscape of long noncoding RNAs in the human transcriptome","volume":"47","author":"M K Iyer","year":"2015","journal-title":"Nat Genet"},{"issue":"01","key":"ref74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/er.2014-1034","article-title":"From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease","volume":"36","author":"M Sun","year":"2015","journal-title":"Endocr Rev"},{"issue":"27","key":"ref75","doi-asserted-by":"crossref","first-page":"17378","DOI":"10.1021\/acsnano.4c02987","article-title":"Emerging mRNA technology for liver disease therapy","volume":"18","author":"J Wang","year":"2024","journal-title":"ACS Nano"},{"issue":"22","key":"ref76","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1021\/acs.nanolett.4c01458","article-title":"Helper lipid-enhanced mRNA delivery for treating metabolic dysfunction-associated fatty liver disease","volume":"24","author":"Z Guo","year":"2024","journal-title":"Nano Lett"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1101\/2023.04.17.537186","article-title":"VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis","author":"F Rizvi","year":"2023","journal-title":"bioRxiv"},{"issue":"10","key":"ref78","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s13346-024-01551-8","article-title":"Liver fibrosis pathologies and potentials of RNA based therapeutics modalities","volume":"14","author":"R Diwan","year":"2024","journal-title":"Drug Deliv Transl Res"},{"issue":"06","key":"ref79","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jhep.2020.12.010","article-title":"Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB\/c.Abcb4-\/- mouse model of PFIC3","volume":"74","author":"G Wei","year":"2021","journal-title":"J Hepatol"},{"issue":"729","key":"ref80","doi-asserted-by":"crossref","first-page":"eadh1334","DOI":"10.1126\/scitranslmed.adh1334","article-title":"mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria","volume":"16","author":"S Gurung","year":"2024","journal-title":"Sci Transl Med"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"8247935","DOI":"10.1155\/2018\/8247935","article-title":"SERPINA1 mRNA as a treatment for alpha-1 antitrypsin deficiency","volume":"2018","author":"B Connolly","year":"2018","journal-title":"J Nucleic Acids"},{"issue":"01","key":"ref82","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41467-021-20903-3","article-title":"Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA","volume":"12","author":"F Rizvi","year":"2021","journal-title":"Nat Commun"},{"issue":"31","key":"ref83","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.2174\/138161282131151013190740","article-title":"RNA interference as a therapeutic strategy for the treatment of liver diseases","volume":"21","author":"A Gonzalez-Rodriguez","year":"2015","journal-title":"Curr Pharm Des"},{"issue":"02","key":"ref84","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s40265-023-01987-1","article-title":"Lumasiran: a review in primary hyperoxaluria type 1","volume":"84","author":"C Kang","year":"2024","journal-title":"Drugs"},{"issue":"03","key":"ref85","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40265-021-01473-6","article-title":"Inclisiran: first approval","volume":"81","author":"Y N Lamb","year":"2021","journal-title":"Drugs"},{"issue":"01","key":"ref86","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00240-023-01453-3","article-title":"Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)","volume":"51","author":"D S Goldfarb","year":"2023","journal-title":"Urolithiasis"},{"issue":"01","key":"ref87","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40291-019-00434-w","article-title":"Leading RNA interference therapeutics part 1: silencing hereditary transthyretin amyloidosis, with a focus on patisiran","volume":"24","author":"S S Titze-de-Almeida","year":"2020","journal-title":"Mol Diagn Ther"},{"issue":"01","key":"ref88","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"D Adams","year":"2018","journal-title":"N Engl J Med"},{"issue":"15","key":"ref89","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s40265-023-01943-z","article-title":"Vutrisiran: a review in polyneuropathy of hereditary transthyretin-mediated amyloidosis","volume":"83","author":"T Nie","year":"2023","journal-title":"Drugs"},{"issue":"07","key":"ref90","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s40265-021-01511-3","article-title":"Givosiran: a review in acute hepatic porphyria","volume":"81","author":"Y Y Syed","year":"2021","journal-title":"Drugs"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"114432","DOI":"10.1016\/j.bcp.2021.114432","article-title":"The growth of siRNA-based therapeutics: Updated clinical studies","volume":"189","author":"M M Zhang","year":"2021","journal-title":"Biochem Pharmacol"},{"issue":"06","key":"ref92","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2205416","article-title":"Fazirsiran for liver disease associated with alpha1-antitrypsin deficiency","volume":"387","author":"P Strnad","year":"2022","journal-title":"N Engl J Med"},{"issue":"12","key":"ref93","doi-asserted-by":"crossref","first-page":"e135348","DOI":"10.1172\/jci.insight.135348","article-title":"Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease","volume":"5","author":"C I Wooddell","year":"2020","journal-title":"JCI Insight"},{"issue":"05","key":"ref94","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2024.06.028","article-title":"Fazirsiran for adults with alpha-1 antitrypsin deficiency liver disease: a phase 2 placebo controlled trial (SEQUOIA)","volume":"167","author":"V C Clark","year":"2024","journal-title":"Gastroenterology"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/bs.pmbts.2023.12.005","article-title":"An update on the therapeutic role of RNAi in NAFLD\/NASH","volume":"204","author":"H Dehghan","year":"2024","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"04","key":"ref96","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jhep.2022.11.025","article-title":"A phase I\/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis","volume":"78","author":"L Y Mak","year":"2023","journal-title":"J Hepatol"},{"issue":"04","key":"ref97","doi-asserted-by":"crossref","first-page":"e2217543120","DOI":"10.1073\/pnas.2217543120","article-title":"Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis","volume":"120","author":"P K Luukkonen","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"02","key":"ref98","first-page":"194","article-title":"Inhibition of neuropilin-1 improves non-alcoholic fatty liver disease in high-fat-diet induced obese mouse","volume":"48","author":"J Zhou","year":"2023","journal-title":"Minerva Endocrinol (Torino)"},{"issue":"01","key":"ref99","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/nat.2022.0038","article-title":"Cholesterol-conjugated siRNA silencing Tnf for the treatment of liver macrophage-mediated acute inflammation in nonalcoholic fatty liver disease","volume":"33","author":"K Craig","year":"2023","journal-title":"Nucleic Acid Ther"},{"issue":"07","key":"ref100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cbf.3495","article-title":"Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease","volume":"38","author":"T Li","year":"2020","journal-title":"Cell Biochem Funct"},{"issue":"02","key":"ref101","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41419-020-2293-7","article-title":"Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy","volume":"11","author":"X Jin","year":"2020","journal-title":"Cell Death Dis"},{"issue":"04","key":"ref102","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jcmgh.2021.06.007","article-title":"6-Gingerol ameliorates hepatic steatosis via HNF4\u03b1\/miR-467b-3p\/GPAT1 cascade","volume":"12","author":"J Ahn","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"12","key":"ref103","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001809","article-title":"LncRNA NEAT1 regulates HCV-induced hepatocellular carcinoma by modulating the miR-9-BGH3 axis","volume":"103","author":"S K Tripathi","year":"2022","journal-title":"J Gen Virol"},{"issue":"01","key":"ref104","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/s41467-024-46172-4","article-title":"Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing","volume":"15","author":"D N Fiflis","year":"2024","journal-title":"Nat Commun"},{"issue":"6708","key":"ref105","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1126\/science.adq0553","article-title":"Structure-guided discovery of ancestral CRISPR-Cas13 ribonucleases","volume":"385","author":"P H Yoon","year":"2024","journal-title":"Science"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"RP91438","DOI":"10.7554\/eLife.91438","article-title":"Hammerhead-type FXR agonists induce an enhancer RNA Fincor that ameliorates nonalcoholic steatohepatitis in mice","volume":"13","author":"J Chen","year":"2024","journal-title":"eLife"},{"issue":"08","key":"ref107","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/hep4.1368","article-title":"Tropifexor-mediated abrogation of steatohepatitis and fibrosis is associated with the antioxidative gene expression profile in rodents","volume":"3","author":"E D Hernandez","year":"2019","journal-title":"Hepatol Commun"},{"issue":"24","key":"ref108","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1021\/acs.jmedchem.7b00907","article-title":"Discovery of tropifexor (LJN452), a highly potent non-bile acid FXR agonist for the treatment of cholestatic liver diseases and nonalcoholic steatohepatitis (NASH)","volume":"60","author":"D C Tully","year":"2017","journal-title":"J Med Chem"},{"issue":"02","key":"ref109","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41591-022-02200-8","article-title":"Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a\/b trial","volume":"29","author":"A J Sanyal","year":"2023","journal-title":"Nat Med"},{"issue":"01","key":"ref110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12943-024-01988-y","article-title":"Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC","volume":"23","author":"Y T Chan","year":"2024","journal-title":"Mol Cancer"},{"issue":"45","key":"ref111","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.1038\/s41388-020-01475-w","article-title":"Aberrant NSUN2-mediated m5C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma","volume":"39","author":"Z Sun","year":"2020","journal-title":"Oncogene"},{"issue":"05","key":"ref112","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1016\/j.ygeno.2020.06.020","article-title":"lncRNA- RP11-156p1.3, novel diagnostic and therapeutic targeting via CRISPR\/Cas9 editing in hepatocellular carcinoma","volume":"112","author":"H S Ali","year":"2020","journal-title":"Genomics"},{"issue":"11","key":"ref113","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.tips.2018.09.001","article-title":"Precision medicine through antisense oligonucleotide-mediated exon skipping","volume":"39","author":"D Li","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"06","key":"ref114","first-page":"e62981","article-title":"RNA interference therapeutics for hereditary amyloidosis: a narrative review of clinical trial outcomes and future directions","volume":"16","author":"P Dave","year":"2024","journal-title":"Cureus"},{"issue":"02","key":"ref115","doi-asserted-by":"crossref","first-page":"102184","DOI":"10.1016\/j.omtn.2024.102184","article-title":"Oligonucleotide therapies for nonalcoholic steatohepatitis","volume":"35","author":"S Li","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"issue":"03","key":"ref116","doi-asserted-by":"crossref","first-page":"100514","DOI":"10.1016\/j.jlr.2024.100514","article-title":"Evaluation of antisense oligonucleotide therapy targeting Hsd17b13 in a fibrosis mice model","volume":"65","author":"Y Ma","year":"2024","journal-title":"J Lipid Res"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"e85131","DOI":"10.7554\/eLife.85131","article-title":"Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (Adgrf1)","volume":"12","author":"M Wu","year":"2023","journal-title":"eLife"},{"issue":"05","key":"ref118","doi-asserted-by":"crossref","first-page":"e21567","DOI":"10.1096\/fj.202002671RR","article-title":"Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease","volume":"35","author":"M Caputo","year":"2021","journal-title":"FASEB J"},{"issue":"02","key":"ref119","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jhep.2021.09.021","article-title":"TTC39B destabilizes retinoblastoma protein promoting hepatic lipogenesis in a sex-specific fashion","volume":"76","author":"J Hsieh","year":"2022","journal-title":"J Hepatol"},{"issue":"09","key":"ref120","doi-asserted-by":"crossref","first-page":"e14853","DOI":"10.14814\/phy2.14853","article-title":"Antisense oligonucleotide-mediated knockdown of Mpzl3 attenuates the negative metabolic effects of diet-induced obesity in mice","volume":"9","author":"B L Worley","year":"2021","journal-title":"Physiol Rep"},{"issue":"06","key":"ref121","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/hep.32083","article-title":"Hepatic mitochondrial SAB deletion or knockdown alleviates diet-induced metabolic syndrome, steatohepatitis, and hepatic fibrosis","volume":"74","author":"S Win","year":"2021","journal-title":"Hepatology"},{"issue":"604","key":"ref122","doi-asserted-by":"crossref","first-page":"eaba9796","DOI":"10.1126\/scitranslmed.aba9796","article-title":"Chop\/Ddit3 depletion in \u03b2 cells alleviates ER stress and corrects hepatic steatosis in mice","volume":"13","author":"J Yong","year":"2021","journal-title":"Sci Transl Med"},{"issue":"599","key":"ref123","doi-asserted-by":"crossref","first-page":"eabe1692","DOI":"10.1126\/scitranslmed.abe1692","article-title":"Hepatocyte TLR4 triggers inter-hepatocyte Jagged1\/Notch signaling to determine NASH-induced fibrosis","volume":"13","author":"J Yu","year":"2021","journal-title":"Sci Transl Med"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"101151","DOI":"10.1016\/j.omtm.2023.101151","article-title":"Generation of hepatitis C virus-resistant liver cells by genome editing-mediated stable expression of RNA aptamer","volume":"31","author":"T H Kim","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"10","key":"ref125","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1038\/mtna.2015.30","article-title":"Pharmacokinetics of a cholesterol-conjugated aptamer against the hepatitis C Virus (HCV) NS5B protein","volume":"4","author":"C H Lee","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"issue":"06","key":"ref126","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.18632\/oncotarget.23564","article-title":"Characterization of aptamer-mediated gene delivery system for liver cancer therapy","volume":"9","author":"Z Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2017.05.017","article-title":"Aptamer-mediated gene therapy enhanced antitumor activity against human hepatocellular carcinoma in vitro and in vivo","volume":"258","author":"S Xiao","year":"2017","journal-title":"J Control Release"},{"issue":"01","key":"ref128","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.bbrc.2011.11.153","article-title":"Regression of hepatocarcinoma cells using RNA aptamer specific to alpha-fetoprotein","volume":"417","author":"Y J Lee","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"01","key":"ref129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.gastro.2012.03.039","article-title":"An RNA aptamer that binds carcinoembryonic antigen inhibits hepatic metastasis of colon cancer cells in mice","volume":"143","author":"Y J Lee","year":"2012","journal-title":"Gastroenterology"},{"issue":"02","key":"ref130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/SLA.0b013e31823e3a1c","article-title":"Osteopontin regulates epithelial mesenchymal transition-associated growth of hepatocellular cancer in a mouse xenograft model","volume":"255","author":"S D Bhattacharya","year":"2012","journal-title":"Ann Surg"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-0716-3191-1_20","article-title":"Methods to study RNA-chromatin interactions","volume":"2666","author":"K Sriram","year":"2023","journal-title":"Methods Mol Biol"},{"issue":"01","key":"ref132","doi-asserted-by":"crossref","first-page":"14196","DOI":"10.1038\/s41598-017-14595-3","article-title":"UClncR: ultrafast and comprehensive long non-coding RNA detection from RNA-seq","volume":"7","author":"Z Sun","year":"2017","journal-title":"Sci Rep"},{"issue":"61","key":"ref133","first-page":"3912","article-title":"Chromatin isolation by RNA purification (ChIRP)","author":"C Chu","year":"2012","journal-title":"J Vis Exp"},{"issue":"09","key":"ref134","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.2943","article-title":"Revealing long noncoding RNA architecture and functions using domain-specific chromatin isolation by RNA purification","volume":"32","author":"J J Quinn","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"05","key":"ref135","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jcmgh.2022.07.017","article-title":"In vivo genome-wide CRISPR activation screening identifies functionally important long noncoding RNAs in hepatocellular carcinoma","volume":"14","author":"L S Wong","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4939-7380-4_6","article-title":"Chromatin RNA immunoprecipitation (ChRIP)","volume":"1689","author":"T Mondal","year":"2018","journal-title":"Methods Mol Biol"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-6380-5_7","article-title":"RIP: RNA immunoprecipitation","volume":"1480","author":"M Gagliardi","year":"2016","journal-title":"Methods Mol Biol"},{"issue":"04","key":"ref138","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.32153","article-title":"The RNA binding protein human antigen R is a gatekeeper of liver homeostasis","volume":"75","author":"P Subramanian","year":"2022","journal-title":"Hepatology"},{"issue":"01","key":"ref139","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijms18010021","article-title":"Long non-coding RNA profiling in a non-alcoholic fatty liver disease rodent model: new insight into pathogenesis","volume":"18","author":"Y Chen","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"19","key":"ref140","doi-asserted-by":"publisher","first-page":"9050","DOI":"10.1093\/nar\/gkw803","article-title":"Identifying proteins that bind to specific RNAs - focus on simple repeat expansion diseases","volume":"44","author":"M Jazurek","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-3378-5_1","article-title":"LncRNA pulldown combined with mass spectrometry to identify the novel LncRNA-associated proteins","volume":"1402","author":"Z Xing","year":"2016","journal-title":"Methods Mol Biol"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2490-1921.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T22:59:55Z","timestamp":1745621995000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2490-1921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":141,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2025,4,25]]},"published-print":{"date-parts":[[2025,3]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2490-1921","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"type":"print","value":"0272-8087"},{"type":"electronic","value":"1098-8971"}],"subject":[],"published-other":{"date-parts":[[2024,11,27]]},"published":{"date-parts":[[2024,11,27]]}}}